Core Insights - Amwell granted RSUs covering 76,198 shares of its Class A common stock to two new employees as an inducement for their employment [1][2] - The RSUs will vest 25% on the first anniversary of the grant date, with the remaining 75% vesting in equal increments every three months over three years [1] Company Overview - Amwell provides a comprehensive, technology-enabled care platform for payers and health systems, enhancing patient access to affordable and effective care [3] - The platform supports various clinical programs and offers integrated solutions for millions of patients, demonstrating scalability and dependable outcomes [3] - Amwell has been serving major healthcare organizations in the U.S. and globally for nearly two decades [3]

Core Insights - American Well Corporation (AMWL) reported revenue of $70.9 million for the quarter ended June 2025, reflecting a year-over-year increase of 12.9% and surpassing the Zacks Consensus Estimate by 11.42% [1] - The company's EPS was -$1.24, an improvement from -$3.36 in the same quarter last year, with a surprise of 32.61% compared to the consensus estimate of -$1.84 [1] Revenue Breakdown - Platform subscription revenue reached $40.46 million, exceeding the average estimate of $34.05 million by two analysts, marking a year-over-year increase of 47.1% [4] - Other revenue amounted to $7.69 million, surpassing the average estimate of $5.7 million, with a year-over-year change of 17.2% [4] - Revenue from visits was $22.75 million, slightly above the estimated $21.68 million, but represented a decline of 20.8% compared to the previous year [4] Stock Performance - Over the past month, shares of American Well have declined by 13.7%, contrasting with a 1% increase in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Group 1 - American Well Corporation (AMWL) reported a quarterly loss of $1.24 per share, which was better than the Zacks Consensus Estimate of a loss of $1.84, and an improvement from a loss of $3.36 per share a year ago, resulting in an earnings surprise of +32.61% [1] - The company posted revenues of $70.9 million for the quarter ended June 2025, exceeding the Zacks Consensus Estimate by 11.42%, and showing an increase from year-ago revenues of $62.79 million [2] - American Well has surpassed consensus EPS estimates four times over the last four quarters and has topped consensus revenue estimates three times during the same period [2] Group 2 - The stock has underperformed the market, losing about 2.9% since the beginning of the year, while the S&P 500 has gained 7.6% [3] - The current consensus EPS estimate for the upcoming quarter is -$1.98 on revenues of $63.11 million, and for the current fiscal year, it is -$6.91 on revenues of $255.84 million [7] - The Medical Info Systems industry, to which American Well belongs, is currently ranked in the top 29% of over 250 Zacks industries, indicating a favorable outlook compared to lower-ranked industries [8]

American Well (AMWL) Q2 2025 Earnings Call August 05, 2025 05:00 PM ET Speaker0Good day, and thank you for standing by. Welcome to the AmWell Second Quarter twenty twenty five Earnings Conference Call. At this time, participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session. Please be advised that today's conference is being recorded.I would now like to hand the conference over to your speaker today, Sue Dooley, Head of Investor Relations. Please go ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39515 American Well Corporation (Exact name of registrant as specified in its charter) (State of incorporation) (I.R.S. Employer De ...

Amwell ® Announces Results for the Second Quarter Ended June 30, 2025 BOSTON – August 5, 2025 – Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the second quarter of 2025. "In Q2, we pursued our strategic initiatives with focus and strong execution. We added Florida Blue, an innovative, large health plan, to our list of strategic clients. We also announced the extension award from the US Defense Health Agen ...

BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the second quarter ended June 30. The company’s second quarter earnings report may be viewed at investors.amwell.com. Amwell will host a conference call to discuss its financial results today at 5 p.m. ET. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/ve8zytc3/. A webcast repla ...

Core Insights - Amwell has been awarded an extension of its Digital First contract to support the digital transformation of the Military Health System (MHS), which serves approximately 9.6 million beneficiaries [1][6] - The contract extension allows Amwell to continue providing its technology-enabled care platform for virtual care, which has been successfully deployed across the global Department of Defense (DOD) enterprise [2][5] - The platform has replaced the previous MHS Video Connect solution, integrating fully with the MHS electronic health record to enhance care delivery for military personnel and their families [3][5] Company Contributions - Amwell's platform contributes to efficiency initiatives, reducing burdens on care teams, improving health outcomes, and optimizing the utilization of clinical resources within the Defense Health Agency (DHA) [4][5] - The platform supports the DHA's Digital Front Door initiative, enhancing capabilities within MHS GENESIS, an advanced electronic health record system [5] - Amwell's technology enables hybrid care, improving access to healthcare and outcomes for the MHS community [5] Performance Highlights - There has been a nearly tripling of virtual visits since the implementation of Amwell's platform, indicating significant adoption and effectiveness [8] - The platform has expanded beyond DHA sites to include beneficiaries from the U.S. Coast Guard and U.S. Military Entrance Processing Command [8] - Successful virtual visits have been conducted from deployed units in combat zones, demonstrating the platform's capability to connect military personnel with healthcare providers [8]

Company Overview - American Well Corporation (AMWL) shares increased by 5% in the last trading session, closing at $8.59, with notable trading volume compared to typical sessions [1] - The stock has gained 12.2% over the past four weeks [1] Financial Performance Expectations - American Well is expected to report a quarterly loss of $1.84 per share, reflecting a year-over-year improvement of 45.2% [3] - Revenue for the upcoming quarter is anticipated to be $63.63 million, which is a 1.3% increase from the same quarter last year [3] - The consensus estimate for the second quarter revenue and loss per share indicates improvements of 1.3% and 45.2%, respectively [2] Earnings Estimate Trends - The consensus EPS estimate for American Well has remained unchanged over the last 30 days, suggesting that stock price movements may not continue without trends in earnings estimate revisions [4] - Empirical research indicates a strong correlation between earnings estimate revisions and near-term stock price movements, highlighting the importance of monitoring these trends [3][4] Industry Context - American Well operates within the Zacks Medical Info Systems industry, where Omnicell (OMCL) is another player, having closed the last trading session at $28.2, down 0.2% [4] - Omnicell's consensus EPS estimate has changed by +42.1% over the past month, but this represents a year-over-year decline of 39.2% [5]

Core Viewpoint - Amwell is set to report its second quarter 2025 operating results on August 5, 2025, after market hours, followed by a live conference call to discuss the results and provide a business update [1]. Company Overview - Amwell provides a comprehensive SaaS-based software platform aimed at technology-enabled healthcare, facilitating better access to convenient, affordable, and effective care for patients [3]. - The platform integrates software and services that support various clinical programs, allowing for personalized access to diverse healthcare services [3]. - Amwell has been operational for nearly two decades, serving major healthcare organizations in the U.S. and globally, and is capable of delivering care to millions of patients [3]. Upcoming Events - Company executives will participate in investor conferences, including one-on-one meetings at the Wells Fargo Healthcare Conference on September 4 and the Morgan Stanley Global Healthcare Conference on September 9 [4].